Collegium to Present at Jefferies and William Blair Conferences

CANTON, Mass., June 02, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that management will present at the following investor conferences in June:

• Jefferies Healthcare Conference, New York, June 7th at 10 a.m. ET
• William Blair Annual Growth Stock Conference, Chicago, June 16th at 10 a.m. CT

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its proprietary DETERx® technology platform for the treatment of chronic pain and other diseases. The DETERx technology platform is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.

About Xtampza ER

Xtampza™ ER is Collegium’s first product utilizing the DETERx technology platform. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone approved by the FDA for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.

For Important Safety Information Visit, http://www.xtampzaer.com/

Contact:
Douglas Carlson
Vice President, Corporate Development
[email protected]

You May Also Be Interested In

• Barclays flags an "attractive entry point" in this pharma stock
• $100M Multicoin Bet Dominates Hyperliquid News as AlphaPepe’s Smaller-Cap Setup Pulls Risk-Hungry Buyers
• F4 Announces Grant of Restricted Share Units